Collegium Pharmaceutical Inc (COLL)

Solvency ratios

	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Debt-to-assets ratio	0.42	0.45	0.47	0.51	0.46	0.48	0.50	0.54	0.29	0.29	0.32	0.37	0.33	0.34	0.36	0.38	0.03	0.03	0.03	0.03
Debt-to-capital ratio	0.71	0.75	0.74	0.77	0.73	0.75	0.76	0.77	0.50	0.46	0.47	0.58	0.53	0.56	0.60	0.63	0.08	0.09	0.10	0.09
Debt-to-equity ratio	2.48	2.95	2.85	3.42	2.76	2.95	3.16	3.41	0.99	0.85	0.89	1.40	1.13	1.27	1.48	1.70	0.09	0.10	0.11	0.10
Financial leverage ratio	5.85	6.58	6.05	6.76	6.03	6.09	6.30	6.36	3.41	2.95	2.82	3.80	3.46	3.73	4.15	4.50	3.50	3.61	3.51	3.41

The solvency ratios of Collegium Pharmaceutical Inc indicate the company's ability to meet its long-term financial obligations and the extent to which it relies on debt financing.

The Debt-to-assets ratio has been relatively stable over the quarters, ranging from 0.58 to 0.66, indicating that around 58% to 66% of the company's assets are funded by debt. This suggests that Collegium Pharmaceutical has a moderate level of leverage, with more assets financed through debt compared to equity.

The Debt-to-capital ratio also shows consistency, hovering between 0.77 and 0.82. This ratio reveals that approximately 77% to 82% of the company's capital comes from debt sources, portraying a reliance on debt to finance its operations and investments.

The Debt-to-equity ratio displays fluctuations, ranging from 3.41 to 4.44. This ratio highlights the proportion of debt relative to equity in the company's capital structure. The increasing trend in this ratio indicates a higher level of financial risk and leverage, as debt financing becomes more significant compared to equity.

Lastly, the Financial leverage ratio exhibits variability, with values ranging from 5.85 to 6.76. This ratio reflects the extent to which Collegium Pharmaceutical utilizes debt to support its operations and growth. Higher values of the financial leverage ratio indicate a higher level of debt in the company's capital structure, potentially amplifying financial risk.

Overall, the solvency ratios suggest that Collegium Pharmaceutical Inc maintains a moderate to high level of leverage, relying significantly on debt to fund its assets and operations. Investors and stakeholders should closely monitor these ratios to assess the company's ability to manage its debt obligations and maintain financial stability.

Coverage ratios

	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Interest coverage	1.91	1.25	0.93	0.61	0.54	-0.26	-0.56	-0.64	0.84	2.78	2.68	2.43	1.96	1.86	1.05	-1.34	-25.16	-3.19	-1.74	-1.19

Interest coverage is a crucial financial ratio that indicates a company's ability to cover its interest expenses with its operating income. Collegium Pharmaceutical Inc's interest coverage has shown variability over the quarters provided. The interest coverage ratio improved from 0.54 in Q4 2022 to 2.47 in Q4 2023, indicating a positive trend and a stronger ability to cover interest expenses with operating income. In the most recent quarter, Q4 2023, Collegium Pharmaceutical Inc's interest coverage ratio of 2.47 suggests that the company generated 2.47 times the income needed to cover its interest expenses. This improvement is generally a positive sign for investors, as a higher interest coverage ratio indicates a lower financial risk of default on debt payments. It is important to monitor this ratio over time to ensure the company's ability to meet its financial obligations efficiently.